Quince Therapeutics Quote - QNCX

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

1.79

Bid

1.68

Offer

1.99

Volume

100

0.00 Day's Range 0.00

0.5116 52 Week Range 2.45

Market Cap

78.763M

Previous Close

1.71

Open

Last Trade

100

1.79

(formt)

Last Trade Time

23:35:01

Financial Volume

VWAP

Average Volume (3m)

649,323

Shares Outstanding

44,001,643

Dividend Yield

PE Ratio

-2.40

Earnings Per Share (EPS)

-0.71

Revenue

Net Profit

-31.39M

Quince Therapeutics, Inc., is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. The company's Phase 3 lead asset, EryDex, is the first product in development that leverages its proprietary Autologous Intracellular Drug ... Quince Therapeutics, Inc., is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. The company's Phase 3 lead asset, EryDex, is the first product in development that leverages its proprietary Autologous Intracellular Drug Encapsulation, or AIDE, technology platform, which is a novel drug/device combination that uses an automated process designed to encapsulate a drug into the patient's own red blood cells. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

quincetx.com

Headquarters

Wilmington, Delaware, USA

Founded

Quince Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker QNCX. The last closing price for Quince Therapeutics was US$1.71. Over the last year, Quince Therapeutics shares have traded in a share price range of US$ 0.5116 to US$ 2.45.

Quince Therapeutics currently has 44,001,643 shares in issue. The market capitalisation of Quince Therapeutics is US$75.24 million. Quince Therapeutics has a price to earnings ratio (PE ratio) of -2.40.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.135	-7.01298701299	1.925	1.97	1.695	185662	1.7630099	CS
4	-0.16	-8.20512820513	1.95	2.0397	1.65	148732	1.82036918	CS
12	0.94	110.588235294	0.85	2.45	0.85	649323	1.4764718	CS
26	1.0396	138.539445629	0.7504	2.45	0.5116	370931	1.28616897	CS
52	0.49	37.6923076923	1.3	2.45	0.5116	230689	1.23243061	CS
156	-8.46	-82.5365853659	10.25	10.58	0.5116	456547	2.05947892	CS
260	-50.16	-96.5543792108	51.95	121.98	0.5116	458188	13.23579758	CS

QNCX - Frequently Asked Questions (FAQ)

What is the current Quince Therapeutics share price?

The current share price of Quince Therapeutics is US$ 1.79

How many Quince Therapeutics shares are in issue?

Quince Therapeutics has 44,001,643 shares in issue

What is the market cap of Quince Therapeutics?

The market capitalisation of Quince Therapeutics is USD 75.24M

What is the 1 year trading range for Quince Therapeutics share price?

Quince Therapeutics has traded in the range of US$ 0.5116 to US$ 2.45 during the past year

What is the PE ratio of Quince Therapeutics?

The price to earnings ratio of Quince Therapeutics is -2.4

What is the reporting currency for Quince Therapeutics?

Quince Therapeutics reports financial results in USD

What is the latest annual profit for Quince Therapeutics?

The latest annual profit of Quince Therapeutics is USD -31.39M

What is the registered address of Quince Therapeutics?

The registered address for Quince Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Quince Therapeutics website address?

The website address for Quince Therapeutics is quincetx.com

Which industry sector does Quince Therapeutics operate in?

Quince Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SGBXSafe and Green Holdings Corporation	US$ 1.05 (94.44%)	47.8M
TAOPTaoping Inc BVI	US$ 0.505 (68.33%)	2.51M
OMCCOld Market Capital Corporation	US$ 10.54 (67.04%)	5
VMARVision Marine Technologies Inc	US$ 2.23 (59.29%)	15.13M
HSDTHelius Medical Technologies Inc	US$ 0.9832 (42.08%)	15.51M
DYNXDynamix Corporation	US$ 5.01 (-48.88%)	1
NESRNational Energy Services Reunited Corporation	US$ 5.11 (-41.47%)	6
WNWMeiwu Technology Company Ltd	US$ 0.6299 (-33.69%)	827.1k
EBMTEagle Bancorp Montana Inc	US$ 10.01 (-31.90%)	6
HTLMHomesToLife Ltd	US$ 5.20 (-31.13%)	406
SGBXSafe and Green Holdings Corporation	US$ 1.05 (94.44%)	47.8M
GCTKGlucoTrack Inc	US$ 0.0973 (-20.25%)	18.64M
HSDTHelius Medical Technologies Inc	US$ 0.9832 (42.08%)	15.51M
VMARVision Marine Technologies Inc	US$ 2.23 (59.29%)	15.13M
WINTWindtree Therapeutics Inc	US$ 0.225 (-9.96%)	13.2M